Journal of Breast Cancer Survival

Aims and Scope

Journal of Breast Cancer Survival (JBCS) is a premier, open-access, peer-reviewed journal dedicated exclusively to breast cancer research, treatment, and survivorship. Our mission is to accelerate progress in breast cancer care by bridging the gap between scientific discovery and clinical application, ultimately enhancing patient outcomes and quality of life.  
 

Why Publish with JBCS?

• Focused & Specialized: Dedicated to the entire journey of breast cancer patients, from diagnosis to survivorship.  
• Comprehensive Scope: Covers molecular biology, epidemiology, novel treatments, and supportive care.  
• Global Reach & Impact: High visibility among oncologists, researchers, and healthcare professionals worldwide.  
• Rigorous Peer Review: Ensuring high-quality, impactful, and clinically relevant research.  
   

Scope of the Journal: JBCS publishes original research, reviews, perspectives, and case reports across all aspects of breast cancer, including:  

• Molecular and biochemical advancements driving new treatment strategies.  
• Innovations in early detection and diagnosis, including medical imaging and biomarker research.  
• Therapeutic approaches, including surgery, radiotherapy, chemotherapy, immunotherapy, and targeted therapies.  
• Epidemiology and population health studies related to risk factors, prevention, and screening programs.  
• Patient-centered research, focusing on survivorship, psychological well-being, rehabilitation, and quality of life.  
• Health economics and public health policies impacting breast cancer care globally.  
• We welcome contributions from oncology, pathology, radiology, psychology, surgery, epidemiology, public health, and beyond.  

JBCS welcome submissions that explore the use of  artificial intelligence in predicting, diagnosing, and treating breast cancer, as well as its impact on patient outcomes and survival rates. Outlined few keywords which suit the journal's scope. For more queries, do contact [email protected]

• Neoplasm
• Chemotherapy
• Cancer Mortality
• Nutrition
• Surgery
• Genetics
• Prevention
• Risk factors
• Radiotherapy
• Drug targeting
• Biomarkers
• Cellular basis of breast cancer
• Therapeutic modalities
• Benign breast diseases
• Imaging
• Cancer genetics
• Molecular classification of disease
• Biophysics of cancer
• Apocrine
• Drug sensitivity and resistance
• Novel imaging
• Chemoprevention strategies
• Tumor genomics
• Estrogen Receptor
• Mucinous
• Metaplastic breast cancer (mpbc)
• Recurrent Disease